WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Postmarket & security

THE TAPE

Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register Elucid raises $55M Series D with FFR-CT 510(k) under FDA review Enovis to buy eCential Robotics for 155 million euros FDA authorizes Vitestro's Aletta, the first autonomous blood-drawing robot, five months after a $70M Series B Renata Medical raises $25M Series D to scale the Minima pediatric stent FDA opens a docket on how to regulate generative AI devices FDA clears Jupiter Endovascular's Vertex thrombectomy system for pulmonary embolism in 89 days FDA clears Wandercraft's Eve, the first self-balancing exoskeleton for home use Meduloc raises $4M Series B to start alpha launch of its nitinol fracture implant FDA sets FY2027 device user fees: $28,653 for a 510(k), $13,785 to register

The Tracker / June 2026 / K253688

510(k) cleared

MEDRAD® Imaging Bulk Package Transfer Spike

Bayer Medical Care, Inc. · Jun 12, 2026 · K253688

FDA cleared the MEDRAD® Imaging Bulk Package Transfer Spike from Bayer Medical Care, Inc. on Jun 12, 2026 under K253688, a traditional 510(k). The device falls under product code PQH, Iodinated Contrast Media Transfer Tubing Set, regulated at 21 CFR 880.5440 as a Class 2 device. The review panel was General Hospital.

FDA logged the submission as received on Nov 21, 2025. The decision came 203 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

Bayer Medical Care, Inc. has one other decision in the tracker over the last 12 months: K252891 (MEDRAD MRXperion MR Injection System and MR Injection System Syringe Kit; MEDRAD ISI2 Module (ISI2)).

Questions & Answers

What did FDA clear under K253688?

K253688 is the FDA 510(k) for MEDRAD® Imaging Bulk Package Transfer Spike, submitted by Bayer Medical Care, Inc.. FDA's decision date was Jun 12, 2026, under product code PQH (Iodinated Contrast Media Transfer Tubing Set).

Who makes the MEDRAD® Imaging Bulk Package Transfer Spike?

Bayer Medical Care, Inc., based in Indianaola, PA, is the applicant of record for K253688.

How long did the K253688 review take?

FDA received the submission on Nov 21, 2025 and issued its decision on Jun 12, 2026, 203 days later.

← All decisions in June 2026

Sources